- |||||||||| CC-1 / University Hospital Tuebingen
Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Checkpoint inhibition, Checkpoint block: Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung (clinicaltrials.gov) - Jul 27, 2023 P1/2, N=3, Terminated, Trial completion date: Aug 2023 --> Dec 2024 | Trial primary completion date: Mar 2023 --> Dec 2024 N=86 --> 3 | Trial completion date: Sep 2025 --> May 2023 | Recruiting --> Terminated | Trial primary completion date: Mar 2025 --> May 2023; premature termination of the trial due to bad recruitment
- |||||||||| CC-1 / University Hospital Tuebingen
Enrollment open: ProSperACC-1: Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer (clinicaltrials.gov) - Jan 12, 2023 P1, N=56, Recruiting, N=86 --> 3 | Trial completion date: Sep 2025 --> May 2023 | Recruiting --> Terminated | Trial primary completion date: Mar 2025 --> May 2023; premature termination of the trial due to bad recruitment Not yet recruiting --> Recruiting
- |||||||||| CC-1 / University Hospital Tuebingen
Trial completion date, Trial primary completion date, Checkpoint inhibition, Checkpoint block: Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung (clinicaltrials.gov) - Dec 14, 2021 P1/2, N=86, Not yet recruiting, Not yet recruiting --> Recruiting Trial completion date: Jan 2025 --> Sep 2025 | Trial primary completion date: May 2023 --> Mar 2025
- |||||||||| CC-1 / University Hospital Tuebingen
Trial completion date, Trial initiation date, Trial primary completion date, Checkpoint inhibition, Checkpoint block: Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung (clinicaltrials.gov) - Mar 9, 2021 P1/2, N=86, Not yet recruiting, Trial completion date: Jan 2025 --> Sep 2025 | Trial primary completion date: May 2023 --> Mar 2025 Trial completion date: May 2024 --> Jan 2025 | Initiation date: Sep 2020 --> May 2021 | Trial primary completion date: Sep 2023 --> May 2023
|